Sean Bohen

Sean Bohen

Chief Executive Officer at OLEMA PHARMACEUTICALS, INC.

Net worth: 3 M $ as of 2026-07-30

59 year
Health Technology
Consumer Services
Miscellaneous

Profile

Sean P.
Bohen
is President, Chief Executive Officer & Director at Olema Pharmaceuticals, Inc. since 2026, Director at Gyroscope Therapeutics Ltd. since 2020, and Non-Executive Director at AltruBio, Inc. since 2019.
Former roles include Non-Executive Director at Gyroscope Therapeutics Holdings Plc from 2020 to 2022, Senior Vice President-Early Development at Genentech, Inc. from 2003 to 2015, Chief Medical Officer & Executive Vice President at AstraZeneca PLC from 2015 to 2019, and Associate at Howard Hughes Medical Institute, Inc. from 2000 to 2003.
Education includes undergraduate studies at the University of Wisconsin and a doctorate from The University of California, San Francisco.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-22 237,650 ( 0.27% ) 3 M $ 2026-07-30

Sean Bohen active positions

CompaniesPositionStart
OLEMA PHARMACEUTICALS, INC. Chief Executive Officer 2020-08-31
Director/Board Member 2020-09-10
Director/Board Member 2019-07-31

Former positions of Sean Bohen

CompaniesPositionEnd
GYROSCOPE THERAPEUTICS HOLDINGS PLC Director/Board Member 2022-02-16
ASTRAZENECA PLC Chief Tech/Sci/R&D Officer 2019-01-13
Corporate Officer/Principal 2015-06-30
Corporate Officer/Principal 2002-12-31
See the detail of Sean Bohen's experience

Training of Sean Bohen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

94

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Miscellaneous

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology